Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

311 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Lack of additive effect between mechanisms of resistance to carbapenems and other beta-lactam agents in Pseudomonas aeruginosa.
Dib C, Trias J, Jarlier V. Dib C, et al. Among authors: jarlier v. Eur J Clin Microbiol Infect Dis. 1995 Nov;14(11):979-86. doi: 10.1007/BF01691380. Eur J Clin Microbiol Infect Dis. 1995. PMID: 8654449
[Antibacterial effect of cefixime in the presence of the type of beta-lactamases produced by Enterobacteriaceae].
Philippon A, Jarlier V, Legrand P, Fournier G, Nicolas MH, Duval J. Philippon A, et al. Among authors: jarlier v. Presse Med. 1989 Oct 11;18(32):1560-6. Presse Med. 1989. PMID: 2530532 French.
Resistance to quinolones in mycobacteria.
Cambau E, Jarlier V. Cambau E, et al. Among authors: jarlier v. Res Microbiol. 1996 Jan-Feb;147(1-2):52-9. doi: 10.1016/0923-2508(96)80204-x. Res Microbiol. 1996. PMID: 8761723 Review. No abstract available.
Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae.
Jarlier V, Gutmann L, Nikaido H. Jarlier V, et al. Antimicrob Agents Chemother. 1991 Sep;35(9):1937-9. doi: 10.1128/aac.35.9.1937. Antimicrob Agents Chemother. 1991. PMID: 1952873 Free PMC article.
Porins in the cell wall of mycobacteria.
Trias J, Jarlier V, Benz R. Trias J, et al. Among authors: jarlier v. Science. 1992 Nov 27;258(5087):1479-81. doi: 10.1126/science.1279810. Science. 1992. PMID: 1279810
The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System.
de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H. de Kraker ME, et al. Among authors: jarlier v. Clin Microbiol Infect. 2013 Sep;19(9):860-8. doi: 10.1111/1469-0691.12028. Epub 2012 Oct 8. Clin Microbiol Infect. 2013. PMID: 23039210
[Carbapenemase-producing enterobacteriae: epidemiology, strategies to control their spread and issues].
Lepelletier D, Batard E, Berthelot P, Zahar JR, Lucet JC, Fournier S, Jarlier V, Grandbastien B. Lepelletier D, et al. Among authors: jarlier v. Rev Med Interne. 2015 Jul;36(7):474-9. doi: 10.1016/j.revmed.2014.12.006. Epub 2015 Jan 15. Rev Med Interne. 2015. PMID: 25600328 Review. French.
Healthcare-associated infections: think globally, act locally.
Marcel JP, Alfa M, Baquero F, Etienne J, Goossens H, Harbarth S, Hryniewicz W, Jarvis W, Kaku M, Leclercq R, Levy S, Mazel D, Nercelles P, Perl T, Pittet D, Vandenbroucke-Grauls C, Woodford N, Jarlier V. Marcel JP, et al. Among authors: jarlier v. Clin Microbiol Infect. 2008 Oct;14(10):895-907. doi: 10.1111/j.1469-0691.2008.02074.x. Clin Microbiol Infect. 2008. PMID: 18828851 Review.
Increase in hospital-acquired bloodstream infections caused by extended spectrum beta-lactamase-producing Escherichia coli in a large French teaching hospital.
Drieux L, Brossier F, Duquesnoy O, Aubry A, Robert J, Sougakoff W, Lecso-Bornet M, Jarlier V. Drieux L, et al. Among authors: jarlier v. Eur J Clin Microbiol Infect Dis. 2009 May;28(5):491-8. doi: 10.1007/s10096-008-0656-6. Epub 2008 Nov 12. Eur J Clin Microbiol Infect Dis. 2009. PMID: 19002728
Interpreting carbapenem susceptibility testing results for Pseudomonas aeruginosa.
Micaëlo M, Brossier F, Bréchot N, Luyt CE, Lu Q, Monsel A, Jarlier V, Aubry A. Micaëlo M, et al. Among authors: jarlier v. Med Mal Infect. 2018 Aug;48(5):365-371. doi: 10.1016/j.medmal.2018.03.003. Epub 2018 Apr 5. Med Mal Infect. 2018. PMID: 29628176
311 results
Jump to page